awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47107471-A1D2C1A6-8187-4887-8535-9A1A4449DCC5
Q47107471-A1D2C1A6-8187-4887-8535-9A1A4449DCC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47107471-A1D2C1A6-8187-4887-8535-9A1A4449DCC5
Emerging treatment options for ovarian cancer: focus on rucaparib.
P2860
Q47107471-A1D2C1A6-8187-4887-8535-9A1A4449DCC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47107471-A1D2C1A6-8187-4887-8535-9A1A4449DCC5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
060cc872828b8dc89eaf89760107a2d3e4e5d466
P2860
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.